Home > Insider Trading > Filing (0001179110-15-010946)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1070081	Ptc Therapeutics Inc.	PTCT	Pharmaceutical Preparations (2834)	043416587

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1251553	P David Southwell	C/O Ptc Therapeutics, Inc. 100 Corporate Court South Plainfield NJ 07080		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2015-07-06	15,000	$10.85	23,604	No	4	M	Direct
Common Stock	Disposition	2015-07-06	22,904	$47.50	700	No	4	S	Direct
Common Stock	Disposition	2015-07-06	700	$48.22	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2015-07-06	15,000	$0.00	15,000	$10.85

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
15,000		2023-05-15	No	4	M	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Option (right to buy)	$51.00	2016-01-02	2025-01-01	12,000	12,000	Direct
Common Stock	Stock Option (right to buy)	$27.05	2015-01-28	2024-01-27	10,000	10,000	Direct
Common Stock	Stock Option (right to buy)	$218.40		2022-01-10	110	110	Direct
Common Stock	Stock Option (right to buy)	$490.80		2021-04-27	110	110	Direct
Common Stock	Stock Option (right to buy)	$1,149.60		2020-02-02	95	95	Direct
Common Stock	Stock Option (right to buy)	$508.80		2019-10-07	108	108	Direct
Common Stock	Stock Option (right to buy)	$735.60		2018-01-25	83	83	Direct
Common Stock	Stock Option (right to buy)	$626.40		2017-04-18	83	83	Direct
Common Stock	Stock Option (right to buy)	$392.40		2016-03-01	125	125	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2025-01-01	12,000	12,000	Direct
2024-01-27	10,000	10,000	Direct
2022-01-10	110	110	Direct
2021-04-27	110	110	Direct
2020-02-02	95	95	Direct
2019-10-07	108	108	Direct
2018-01-25	83	83	Direct
2017-04-18	83	83	Direct
2016-03-01	125	125	Direct

Footnotes

The transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person for the primary purpose of diversification.
This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $47.13 to $48.09 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $48.16 to $48.27 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
This option was granted on May 15, 2013 and vests over three years, with 8.33% of the shares underlying the option vested on August 15, 2013 and an additional 8.33% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter.
Currently exercisable.